Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00104273
What this trial is testing

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
DementiaAlzheimer's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 376
Early research (Phase 1)UnknownNCT00599469
What this trial is testing

Far Infrared Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer Disease
GAAD Medical Research Institute Inc. 4
Not applicableUnknownNCT05113732
What this trial is testing

Association of Cognition With Functional Mobility in People With Alzheimer's Disease

Who this might be right for
Alzheimer DementiaAlzheimer's DiseaseDementia, Alzheimer Type
Istanbul University - Cerrahpasa 64
Not applicableActive Not RecruitingNCT05779839
What this trial is testing

Caregiver Connections Via Technology in Dementia

Who this might be right for
Caregiver StressDementiaAlzheimer Disease+3 more
Mayo Clinic 355
Testing effectiveness (Phase 2)Study completedNCT00470418
What this trial is testing

Development of NIC5-15 in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
VA Office of Research and Development 15
Not applicableStudy completedNCT04851691
What this trial is testing

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

Who this might be right for
Alzheimer DiseaseDementia AlzheimersDementia of Alzheimer Type
University of California, Los Angeles 158
Testing effectiveness (Phase 2)Study completedNCT02185053
What this trial is testing

A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia

Who this might be right for
Alzheimer's Disease
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc 41
Early research (Phase 1)Study completedNCT02502253
What this trial is testing

BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Johns Hopkins University 14
Post-approval studies (Phase 4)WithdrawnNCT00711204
What this trial is testing

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Who this might be right for
Severe Alzheimer's Disease
Eisai Inc.
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Not applicableLooking for participantsNCT00869817
What this trial is testing

Dominantly Inherited Alzheimer Network (DIAN)

Who this might be right for
Alzheimer's Disease
Washington University School of Medicine 700
Large-scale testing (Phase 3)Study completedNCT04797715
What this trial is testing

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 178
Post-approval studies (Phase 4)Study completedNCT01478633
What this trial is testing

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 102
Not applicableStudy completedNCT02501876
What this trial is testing

Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease

Who this might be right for
Alzheimer´s DiseaseDiabetes Mellitus Type 2
Hospital Universitari Vall d'Hebron Research Institute 202
Post-approval studies (Phase 4)Study completedNCT00505167
What this trial is testing

Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
Hospital Miguel Servet 64
Not applicableWithdrawnNCT04942184
What this trial is testing

STRATEGIES to Improve Memory in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, MildMild Cognitive Impairment
Boston University
Not applicableLooking for participantsNCT03890861
What this trial is testing

Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"

Who this might be right for
Dementia, Alzheimer Type
Pennington Biomedical Research Center 125
Not applicableStudy completedNCT02460783
What this trial is testing

Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function

Who this might be right for
Alzheimer's DiseaseObesityDiabetes Mellitus
National Institute on Aging (NIA) 129
Not applicableStudy completedNCT03153371
What this trial is testing

Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks

Who this might be right for
Alzheimer Disease, Early OnsetAlzheimer DiseaseAlzheimer Disease, Late Onset+8 more
University of California, Los Angeles 180
Testing effectiveness (Phase 2)Looking for participantsNCT07688213
What this trial is testing

Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer's TypeAlzheimer's Disease
Sanofi 160
Next Page